Application Nr Approved Date Route Status External Links
ANDA076598 None Nasal None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Ipratropium Bromide Nasal Solution 0.06% Is Indicated For The Symptomatic Relief Of Rhinorrhea Associated With The Common Cold Or Seasonal Allergic Rhinitis For Adults And Children Age 5 Years And Older. Ipratropium Bromide 0.06% Does Not Relieve Nasal Congestion Or Sneezing Associated With The Common Cold Or Seasonal Allergic Rhinitis. The Safety And Effectiveness Of The Use Of Ipratropium Bromide 0.06% Beyond Four Days In Patients With The Common Cold Or Beyond Three Weeks In Patients With Seasonal Allergic Rhinitis Has Not Been Established.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ipratropium Bromide IPRATROPIUM BROMIDE ZINC100015775

Comments